BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 10817105)

  • 21. A double-blind comparison of fluvoxamine and paroxetine in the treatment of depressed outpatients.
    Kiev A; Feiger A
    J Clin Psychiatry; 1997 Apr; 58(4):146-52. PubMed ID: 9164424
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial.
    Detke MJ; Wiltse CG; Mallinckrodt CH; McNamara RK; Demitrack MA; Bitter I
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):457-70. PubMed ID: 15589385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy and tolerability of venlafaxine and paroxetine in outpatients with depressive disorder or dysthymia.
    Ballús C; Quiros G; De Flores T; de la Torre J; Palao D; Rojo L; Gutiérrez M; Casais L; Riesgo Y
    Int Clin Psychopharmacol; 2000 Jan; 15(1):43-8. PubMed ID: 10836286
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Agomelatine vs Paroxetine Hydrochloride in Chinese Han Patients with Major Depressive Disorder: A Multicentre, Double-Blind, Noninferiority, Randomized Controlled Trial.
    Yu YM; Gao KR; Yu H; Shen YF; Li HF
    J Clin Psychopharmacol; 2018 Jun; 38(3):226-233. PubMed ID: 29620692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bupropion sustained release as a smoking cessation treatment in remitted depressed patients maintained on treatment with selective serotonin reuptake inhibitor antidepressants.
    Chengappa KN; Kambhampati RK; Perkins K; Nigam R; Anderson T; Brar JS; Vemulapalli HK; Atzert R; Key P; Kang JS; Levine J
    J Clin Psychiatry; 2001 Jul; 62(7):503-8. PubMed ID: 11488359
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A prospective safety surveillance study for bupropion sustained-release in the treatment of depression.
    Dunner DL; Zisook S; Billow AA; Batey SR; Johnston JA; Ascher JA
    J Clin Psychiatry; 1998 Jul; 59(7):366-73. PubMed ID: 9714265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of sexual functioning in depressed outpatients: a double-blind comparison of sustained-release bupropion and sertraline treatment.
    Segraves RT; Kavoussi R; Hughes AR; Batey SR; Johnston JA; Donahue R; Ascher JA
    J Clin Psychopharmacol; 2000 Apr; 20(2):122-8. PubMed ID: 10770448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Does negative affectivity predict differential response to an SSRI versus a non-SSRI antidepressant?
    Gerra ML; Marchesi C; Amat JA; Blier P; Hellerstein DJ; Stewart JW
    J Clin Psychiatry; 2014 Sep; 75(9):e939-44. PubMed ID: 25295437
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter double-blind comparison of nefazodone and paroxetine in the treatment of outpatients with moderate-to-severe depression.
    Baldwin DS; Hawley CJ; Abed RT; Maragakis BP; Cox J; Buckingham SA; Pover GH; Ascher A
    J Clin Psychiatry; 1996; 57 Suppl 2():46-52. PubMed ID: 8626363
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety profile of sustained-release bupropion in depression: results of three clinical trials.
    Settle EC; Stahl SM; Batey SR; Johnston JA; Ascher JA
    Clin Ther; 1999 Mar; 21(3):454-63. PubMed ID: 10321415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bupropion sustained release for bereavement: results of an open trial.
    Zisook S; Shuchter SR; Pedrelli P; Sable J; Deaciuc SC
    J Clin Psychiatry; 2001 Apr; 62(4):227-30. PubMed ID: 11379835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Eight-week, placebo-controlled, double-blind comparison of the antidepressant efficacy and tolerability of bupropion XR and venlafaxine XR.
    Hewett K; Chrzanowski W; Schmitz M; Savela A; Milanova V; Gee M; Krishen A; Millen L; Leary MO; Modell J
    J Psychopharmacol; 2009 Jul; 23(5):531-8. PubMed ID: 18635695
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression.
    Musselman DL; Somerset WI; Guo Y; Manatunga AK; Porter M; Penna S; Lewison B; Goodkin R; Lawson K; Lawson D; Evans DL; Nemeroff CB
    J Clin Psychiatry; 2006 Feb; 67(2):288-96. PubMed ID: 16566626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An open pilot study of the combination of escitalopram and bupropion-SR for outpatients with major depressive disorder.
    Leuchter AF; Lesser IM; Trivedi MH; Rush AJ; Morris DW; Warden D; Fava M; Wisniewski SR; Luther JF; Perales M; Gaynes BN; Stewart JW
    J Psychiatr Pract; 2008 Sep; 14(5):271-80. PubMed ID: 18832958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine.
    Coleman CC; King BR; Bolden-Watson C; Book MJ; Segraves RT; Richard N; Ascher J; Batey S; Jamerson B; Metz A
    Clin Ther; 2001 Jul; 23(7):1040-58. PubMed ID: 11519769
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bupropion in the treatment of outpatients with asthma and major depressive disorder.
    Brown ES; Vornik LA; Khan DA; Rush AJ
    Int J Psychiatry Med; 2007; 37(1):23-8. PubMed ID: 17645195
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relative antidepressant efficacy of bupropion and the selective serotonin reuptake inhibitors in major depressive disorder: gender-age interactions.
    Papakostas GI; Kornstein SG; Clayton AH; Soares CN; Hallett LA; Krishen A; Tucker VL
    Int Clin Psychopharmacol; 2007 Jul; 22(4):226-9. PubMed ID: 17519646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The use of venlafaxine in the treatment of major depression and major depression associated with anxiety: a dose-response study. Venlafaxine Investigator Study Group.
    Khan A; Upton GV; Rudolph RL; Entsuah R; Leventer SM
    J Clin Psychopharmacol; 1998 Feb; 18(1):19-25. PubMed ID: 9472838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mirtazapine compared with paroxetine in major depression.
    Benkert O; Szegedi A; Kohnen R
    J Clin Psychiatry; 2000 Sep; 61(9):656-63. PubMed ID: 11030486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comparative, randomised, double-blind study of trazodone prolonged-release and paroxetine in the treatment of patients with major depressive disorder.
    Kasper S; Olivieri L; Di Loreto G; Dionisio P
    Curr Med Res Opin; 2005 Aug; 21(8):1139-46. PubMed ID: 16083521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.